0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Glucagon Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Published Date: April 2024
|
Report Code: QYRE-Auto-19M646
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Glucagon Market Insights and Forecast to 2028
BUY CHAPTERS

Global Glucagon Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

Code: QYRE-Auto-19M646
Report
April 2024
Pages:129
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Glucagon Market Size

The global Glucagon market is projected to reach US$ 845.7 million by 2030 from an estimated US$ 592.8 million in 2024, at a CAGR of 6.1% during 2024 and 2030.

Glucagon Market

Glucagon Market

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Glucagon, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Glucagon.
The Glucagon market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glucagon market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glucagon manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation

Scope of Glucagon Market Report

Report Metric Details
Report Name Glucagon Market
Accounted market size in 2024 an estimated US$ 592.8 million
Forecasted market size in 2030 US$ 845.7 million
CAGR 6.1%
Base Year 2024
Forecasted years 2024 - 2030
Segment by Type
  • Inject Glucagon
  • Nasal Glucagon
Segment by Application
  • Emergency Kits
  • General Use
  • Diagnostic & Motility
  • Cardiogenic Shock
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals, Xeris Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Glucagon in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Glucagon manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glucagon sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

How fast is Glucagon Market growing?

Ans: The Glucagon Market witnessing a CAGR of 6.1% during the forecast period 2024-2030.

What is the Glucagon Market size in 2030?

Ans: The Glucagon Market size in 2030 will be US$ 845.7 million.

What is the market share of major companies in Glucagon Market?

Ans: Global top four manufacturers hold a share over 80%.

What is the Glucagon Market share by region?

Ans: North America is the largest market, with a share nearly 40%.

Who are the main players in the Glucagon Market report?

Ans: The main players in the Glucagon Market are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals, Xeris Pharmaceuticals

What are the Application segmentation covered in the Glucagon Market report?

Ans: The Applications covered in the Glucagon Market report are Emergency Kits, General Use, Diagnostic & Motility, Cardiogenic Shock, Others

What are the Type segmentation covered in the Glucagon Market report?

Ans: The Types covered in the Glucagon Market report are Inject Glucagon, Nasal Glucagon

1 Study Coverage
1.1 Glucagon Product Introduction
1.2 Market by Type
1.2.1 Global Glucagon Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Inject Glucagon
1.2.3 Nasal Glucagon
1.3 Market by Application
1.3.1 Global Glucagon Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Emergency Kits
1.3.3 General Use
1.3.4 Diagnostic & Motility
1.3.5 Cardiogenic Shock
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Glucagon Market Size Estimates and Forecasts
2.1.1 Global Glucagon Revenue 2019-2030
2.1.2 Global Glucagon Sales 2019-2030
2.2 Glucagon Market Size by Region: 2023 Versus 2030
2.3 Glucagon Sales by Region (2019-2030)
2.3.1 Global Glucagon Sales by Region: 2019-2024
2.3.2 Global Glucagon Sales Forecast by Region (2025-2030)
2.3.3 Global Glucagon Sales Market Share by Region (2019-2030)
2.4 Glucagon Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Glucagon Revenue by Region: 2019-2024
2.4.2 Global Glucagon Revenue Forecast by Region (2025-2030)
2.4.3 Global Glucagon Revenue Market Share by Region (2019-2030)
3 Global Glucagon by Manufacturers
3.1 Global Top Glucagon Manufacturers by Sales
3.1.1 Global Glucagon Sales by Manufacturer (2019-2024)
3.1.2 Global Glucagon Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Glucagon Manufacturers by Revenue
3.2.1 Global Glucagon Revenue by Manufacturer (2019-2024)
3.2.2 Global Glucagon Revenue Share by Manufacturer (2019-2024)
3.3 Global Glucagon Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Glucagon Manufacturers Covered: Ranking by Revenue
3.4.2 Global Glucagon Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Glucagon Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Glucagon Manufacturing Base Distribution, Product Type
3.5.1 Glucagon Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Glucagon Product Type
3.5.3 Date of International Manufacturers Enter into Glucagon Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Novo Nordisk
4.1.1 Novo Nordisk Company Information
4.1.2 Novo Nordisk Description, Business Overview
4.1.3 Novo Nordisk Glucagon Products Offered
4.1.4 Novo Nordisk Glucagon Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Novo Nordisk Glucagon Sales by Product in 2023
4.1.6 Novo Nordisk Glucagon Sales by Application in 2023
4.1.7 Novo Nordisk Glucagon Sales by Geographic Area in 2023
4.1.8 Novo Nordisk Recent Developments
4.2 Eli Lilly
4.2.1 Eli Lilly Company Information
4.2.2 Eli Lilly Description, Business Overview
4.2.3 Eli Lilly Glucagon Products Offered
4.2.4 Eli Lilly Glucagon Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Eli Lilly Glucagon Sales by Product in 2023
4.2.6 Eli Lilly Glucagon Sales by Application in 2023
4.2.7 Eli Lilly Glucagon Sales by Geographic Area in 2023
4.2.8 Eli Lilly Recent Developments
4.3 Fresenius Kabi
4.3.1 Fresenius Kabi Company Information
4.3.2 Fresenius Kabi Description, Business Overview
4.3.3 Fresenius Kabi Glucagon Products Offered
4.3.4 Fresenius Kabi Glucagon Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Fresenius Kabi Glucagon Sales by Product in 2023
4.3.6 Fresenius Kabi Glucagon Sales by Application in 2023
4.3.7 Fresenius Kabi Glucagon Sales by Geographic Area in 2023
4.3.8 Fresenius Kabi Recent Developments
4.4 Torrent Labs
4.4.1 Torrent Labs Company Information
4.4.2 Torrent Labs Description, Business Overview
4.4.3 Torrent Labs Glucagon Products Offered
4.4.4 Torrent Labs Glucagon Sales, Revenue and Gross Margin (2019-2024)
4.4.5 Torrent Labs Glucagon Sales by Product in 2023
4.4.6 Torrent Labs Glucagon Sales by Application in 2023
4.4.7 Torrent Labs Glucagon Sales by Geographic Area in 2023
4.4.8 Torrent Labs Recent Developments
4.5 Taj Pharmaceuticals
4.5.1 Taj Pharmaceuticals Company Information
4.5.2 Taj Pharmaceuticals Description, Business Overview
4.5.3 Taj Pharmaceuticals Glucagon Products Offered
4.5.4 Taj Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Taj Pharmaceuticals Glucagon Sales by Product in 2023
4.5.6 Taj Pharmaceuticals Glucagon Sales by Application in 2023
4.5.7 Taj Pharmaceuticals Glucagon Sales by Geographic Area in 2023
4.5.8 Taj Pharmaceuticals Recent Developments
4.6 Xeris Pharmaceuticals
4.6.1 Xeris Pharmaceuticals Company Information
4.6.2 Xeris Pharmaceuticals Description, Business Overview
4.6.3 Xeris Pharmaceuticals Glucagon Products Offered
4.6.4 Xeris Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Xeris Pharmaceuticals Glucagon Sales by Product in 2023
4.6.6 Xeris Pharmaceuticals Glucagon Sales by Application in 2023
4.6.7 Xeris Pharmaceuticals Glucagon Sales by Geographic Area in 2023
4.6.8 Xeris Pharmaceuticals Recent Development
5 Breakdown Data by Type
5.1 Global Glucagon Sales by Type (2019-2030)
5.1.1 Global Glucagon Sales by Type (2019-2024)
5.1.2 Global Glucagon Sales Forecast by Type (2025-2030)
5.1.3 Global Glucagon Sales Market Share by Type (2019-2030)
5.2 Global Glucagon Revenue Forecast by Type (2019-2030)
5.2.1 Global Glucagon Revenue by Type (2019-2024)
5.2.2 Global Glucagon Revenue Forecast by Type (2025-2030)
5.2.3 Global Glucagon Revenue Market Share by Type (2019-2030)
5.3 Glucagon Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Glucagon Sales by Application (2019-2030)
6.1.1 Global Glucagon Sales by Application (2019-2024)
6.1.2 Global Glucagon Sales Forecast by Application (2025-2030)
6.1.3 Global Glucagon Sales Market Share by Application (2019-2030)
6.2 Global Glucagon Revenue Forecast by Application (2019-2030)
6.2.1 Global Glucagon Revenue by Application (2019-2024)
6.2.2 Global Glucagon Revenue Forecast by Application (2025-2030)
6.2.3 Global Glucagon Revenue Market Share by Application (2019-2030)
6.3 Glucagon Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Glucagon Market Size YoY Growth 2019-2030
7.2 North America Glucagon Market Facts & Figures by Country
7.2.1 North America Glucagon Sales by Country (2019-2030)
7.2.2 North America Glucagon Revenue by Country (2019-2030)
7.3 North America Glucagon Sales by Type (2019-2024)
7.4 North America Glucagon Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Glucagon Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Glucagon Market Facts & Figures by Region
8.2.1 Asia-Pacific Glucagon Sales by Region (2019-2030)
8.2.2 Asia-Pacific Glucagon Revenue by Region (2019-2030)
8.3 Asia-Pacific Glucagon Sales by Type (2019-2024)
8.4 Asia-Pacific Glucagon Sales by Application (2019-2024)
9 Europe
9.1 Europe Glucagon Market Size YoY Growth 2019-2030
9.2 Europe Glucagon Market Facts & Figures by Country
9.2.1 Europe Glucagon Sales by Country (2019-2030)
9.2.2 Europe Glucagon Revenue by Country (2019-2030)
9.3 Europe Glucagon Sales by Type (2019-2024)
9.4 Europe Glucagon Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Glucagon Market Size YoY Growth 2019-2030
10.2 Latin America Glucagon Market Facts & Figures by Country
10.2.1 Latin America Glucagon Sales by Country (2019-2030)
10.2.2 Latin America Glucagon Revenue by Country (2019-2030)
10.3 Latin America Glucagon Sales by Type (2019-2024)
10.4 Latin America Glucagon Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Glucagon Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Glucagon Market Facts & Figures by Country
11.2.1 Middle East and Africa Glucagon Sales by Country (2019-2030)
11.2.2 Middle East and Africa Glucagon Revenue by Country (2019-2030)
11.3 Middle East and Africa Glucagon Sales by Type (2019-2024)
11.4 Middle East and Africa Glucagon Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Glucagon Supply Chain Analysis
12.2 Glucagon Key Raw Materials and Upstream Suppliers
12.3 Glucagon Clients Analysis
12.4 Glucagon Sales Channel and Sales Model Analysis
12.4.1 Glucagon Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Glucagon Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Glucagon Distributors
13 Market Dynamics
13.1 Glucagon Industry Trends
13.2 Glucagon Market Drivers
13.3 Glucagon Market Challenges
13.4 Glucagon Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Glucagon Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Major Manufacturers of Inject Glucagon
    Table 3. Major Manufacturers of Nasal Glucagon
    Table 4. Global Glucagon Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Glucagon Market Size by Region (US$ Million): 2023 VS 2030
    Table 6. Global Glucagon Sales by Region (2019-2024) & (K MT)
    Table 7. Global Glucagon Sales Forecast by Region (2025-2030) & (K MT)
    Table 8. Global Glucagon Revenue by Region (2019-2024) & (US$ Million)
    Table 9. Global Glucagon Revenue Forecast by Region (2025-2030) & (US$ Million)
    Table 10. Global Glucagon Sales by Manufacturer (2019-2024) & (K MT)
    Table 11. Global Glucagon Sales Share by Manufacturer (2019-2024)
    Table 12. Glucagon Revenue by Manufacturer (2019-2024) & (US$ Million)
    Table 13. Glucagon Revenue Share by Manufacturer (2019-2024)
    Table 14. Key Manufacturers Glucagon Price (2019-2024) & (USD/MT)
    Table 15. Ranking of Global Top Glucagon Manufacturers by Revenue (US$ Million) in 2023
    Table 16. Global Glucagon Manufacturers Market Concentration Ratio (CR5 and HHI) & (2019-2024)
    Table 17. Global Glucagon by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glucagon as of 2023)
    Table 18. Glucagon Manufacturers Manufacturing Base Distribution and Headquarters
    Table 19. Manufacturers Glucagon Product Type
    Table 20. Date of International Manufacturers Enter into Glucagon Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Novo Nordisk Company Information
    Table 23. Novo Nordisk Description and Business Overview
    Table 24. Novo Nordisk Glucagon Product
    Table 25. Novo Nordisk Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 26. Novo Nordisk Sales Proportion of Glucagon by Product in 2023
    Table 27. Novo Nordisk Sales Proportion of Glucagon by Application in 2023
    Table 28. Novo Nordisk Sales Proportion of Glucagon by Geographic Area in 2023
    Table 29. Novo Nordisk Recent Development
    Table 30. Eli Lilly Company Information
    Table 31. Eli Lilly Description and Business Overview
    Table 32. Eli Lilly Glucagon Product
    Table 33. Eli Lilly Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 34. Eli Lilly Sales Proportion of Glucagon by Product in 2023
    Table 35. Eli Lilly Sales Proportion of Glucagon by Application in 2023
    Table 36. Eli Lilly Sales Proportion of Glucagon by Geographic Area in 2023
    Table 37. Eli Lilly Recent Development
    Table 38. Fresenius Kabi Company Information
    Table 39. Fresenius Kabi Description and Business Overview
    Table 40. Fresenius Kabi Glucagon Product
    Table 41. Fresenius Kabi Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 42. Fresenius Kabi Sales Proportion of Glucagon by Product in 2023
    Table 43. Fresenius Kabi Sales Proportion of Glucagon by Application in 2023
    Table 44. Fresenius Kabi Sales Proportion of Glucagon by Geographic Area in 2023
    Table 45. Fresenius Kabi Recent Development
    Table 46. Torrent Labs Company Information
    Table 47. Torrent Labs Description and Business Overview
    Table 48. Torrent Labs Glucagon Product
    Table 49. Torrent Labs Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 50. Torrent Labs Sales Proportion of Glucagon by Product in 2023
    Table 51. Torrent Labs Sales Proportion of Glucagon by Application in 2023
    Table 52. Torrent Labs Sales Proportion of Glucagon by Geographic Area in 2023
    Table 53. Torrent Labs Recent Development
    Table 54. Taj Pharmaceuticals Company Information
    Table 55. Taj Pharmaceuticals Description and Business Overview
    Table 56. Taj Pharmaceuticals Glucagon Product
    Table 57. Taj Pharmaceuticals Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 58. Taj Pharmaceuticals Sales Proportion of Glucagon by Product in 2023
    Table 59. Taj Pharmaceuticals Sales Proportion of Glucagon by Application in 2023
    Table 60. Taj Pharmaceuticals Sales Proportion of Glucagon by Geographic Area in 2023
    Table 61. Taj Pharmaceuticals Recent Development
    Table 62. Xeris Pharmaceuticals Company Information
    Table 63. Xeris Pharmaceuticals Description and Business Overview
    Table 64. Xeris Pharmaceuticals Glucagon Product
    Table 65. Xeris Pharmaceuticals Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 66. Xeris Pharmaceuticals Sales Proportion of Glucagon by Product in 2023
    Table 67. Xeris Pharmaceuticals Sales Proportion of Glucagon by Application in 2023
    Table 68. Xeris Pharmaceuticals Sales Proportion of Glucagon by Geographic Area in 2023
    Table 69. Xeris Pharmaceuticals Recent Development
    Table 70. Global Glucagon Sales by Type (2019-2024) & (K MT)
    Table 71. Global Glucagon Sales Forecast by Type (2025-2030) & (K MT)
    Table 72. Global Glucagon Revenue by Type (2019-2024) & (US$ Million)
    Table 73. Global Glucagon Revenue Forecast by Type (2025-2030) & (US$ Million)
    Table 74. Global Glucagon Sales by Application (2019-2024) & (K MT)
    Table 75. Global Glucagon Sales Forecast by Application (2025-2030) & (K MT)
    Table 76. Global Glucagon Revenue by Application (2019-2024) & (US$ Million)
    Table 77. Global Glucagon Revenue Forecast by Application (2025-2030) & (US$ Million)
    Table 78. North America Glucagon Sales by Country (2019-2024) & (K MT)
    Table 79. North America Glucagon Sales by Country (2025-2030) & (K MT)
    Table 80. North America Glucagon Revenue by Country (2019-2024) & (US$ Million)
    Table 81. North America Glucagon Revenue by Country (2025-2030) & (US$ Million)
    Table 82. North America Glucagon Sales by Type (2019-2024) & (K MT)
    Table 83. North America Glucagon Sales by Application (2019-2024) & (K MT)
    Table 84. Asia-Pacific Glucagon Sales by Region (2019-2024) & (K MT)
    Table 85. Asia-Pacific Glucagon Sales by Region (2025-2030) & (K MT)
    Table 86. Asia-Pacific Glucagon Revenue by Region (2019-2030) & (US$ Million)
    Table 87. Asia-Pacific Glucagon Revenue by Region (2025-2030) & (US$ Million)
    Table 88. Asia-Pacific Glucagon Sales by Type (2019-2024) & (K MT)
    Table 89. Asia-Pacific Glucagon Sales by Application (2019-2024) & (K MT)
    Table 90. Europe Glucagon Sales by Country (2019-2024) & (K MT)
    Table 91. Europe Glucagon Sales by Country (2025-2030) & (K MT)
    Table 92. Europe Glucagon Revenue by Country (2019-2024) & (US$ Million)
    Table 93. Europe Glucagon Revenue by Country (2025-2030) & (US$ Million)
    Table 94. Europe Glucagon Sales by Type (2019-2024) & (K MT)
    Table 95. Europe Glucagon Sales by Application (2019-2024) & (K MT)
    Table 96. Latin America Glucagon Sales by Country (2019-2024) & (K MT)
    Table 97. Latin America Glucagon Sales by Country (2025-2030) & (K MT)
    Table 98. Latin America Glucagon Revenue by Country (2019-2024) & (US$ Million)
    Table 99. Latin America Glucagon Revenue by Country (2025-2030) & (US$ Million)
    Table 100. Latin America Glucagon Sales by Type (2019-2024) & (K MT)
    Table 101. Latin America Glucagon Sales by Application (2019-2024) & (K MT)
    Table 102. Middle East and Africa Glucagon Sales by Country (2019-2024) & (K MT)
    Table 103. Middle East and Africa Glucagon Sales by Country (2025-2030) & (K MT)
    Table 104. Middle East and Africa Glucagon Revenue by Country (2019-2024) & (US$ Million)
    Table 105. Middle East and Africa Glucagon Revenue by Country (2025-2030) & (US$ Million)
    Table 106. Middle East and Africa Glucagon Sales by Type (2019-2024) & (K MT)
    Table 107. Middle East and Africa Glucagon Sales by Application (2019-2024) & (K MT)
    Table 108. Glucagon Key Raw Materials, Industry Status and Trend
    Table 109. Glucagon Key Raw Materials and Upstream Suppliers
    Table 110. Glucagon Clients Status and Trend
    Table 111. Glucagon Typical Clients
    Table 112. Glucagon Distributors
    Table 113. Glucagon Market Trends
    Table 114. Glucagon Market Drivers
    Table 115. Glucagon Market Challenges
    Table 116. Glucagon Market Restraints
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Glucagon Product Picture
    Figure 2. Global Glucagon Sales Market Share by Type in 2023 & 2030
    Figure 3. Inject Glucagon Product Picture
    Figure 4. Nasal Glucagon Product Picture
    Figure 5. Global Glucagon Sales Market Share by Application in 2023 & 2030
    Figure 6. Emergency Kits Examples
    Figure 7. General Use Examples
    Figure 8. Diagnostic & Motility Examples
    Figure 9. Cardiogenic Shock Examples
    Figure 10. Others Examples
    Figure 11. Glucagon Report Years Considered
    Figure 12. Global Glucagon Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Glucagon Market Size 2019-2030 (US$ Million)
    Figure 14. Global Glucagon Sales 2019-2030 (K MT)
    Figure 15. Global Glucagon Sales Market Share Forecast by Region (2019-2030)
    Figure 16. Global Glucagon Revenue Market Share by Region (2019-2030)
    Figure 17. Global Glucagon Sales Share by Manufacturer in 2023
    Figure 18. Glucagon Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Glucagon Sales Market Share Forecast by Type (2019-2030)
    Figure 20. Global Glucagon Revenue Market Share Forecast by Type (2019-2030)
    Figure 21. Glucagon Average Selling Price (ASP) by Type (2019-2024) & (USD/MT)
    Figure 22. Global Glucagon Sales Market Share Forecast by Application (2019-2030)
    Figure 23. Global Glucagon Revenue Market Share Forecast by Application (2019-2030)
    Figure 24. Glucagon Average Selling Price (ASP) by Application (2019-2024) & (USD/MT)
    Figure 25. North America Glucagon Revenue 2019-2030 (US$ Million)
    Figure 26. North America Glucagon Sales Market Share by Type (2019-2024)
    Figure 27. North America Glucagon Sales Market Share by Application (2019-2024)
    Figure 28. Asia-Pacific Glucagon Revenue 2019-2030 (US$ Million)
    Figure 29. Asia-Pacific Glucagon Sales Market Share by Region (2019-2030)
    Figure 30. Asia-Pacific Glucagon Revenue Market Share by Region (2019-2030)
    Figure 31. Asia-Pacific Glucagon Sales Market Share by Type (2019-2024)
    Figure 32. Asia-Pacific Glucagon Sales Market Share by Application (2019-2024)
    Figure 33. Europe Glucagon Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 34. Europe Glucagon Sales Market Share by Country (2019-2030)
    Figure 35. Europe Glucagon Revenue Market Share by Country (2019-2030)
    Figure 36. Europe Glucagon Sales Market Share by Type (2019-2024)
    Figure 37. Europe Glucagon Sales Market Share by Application (2019-2024)
    Figure 38. Latin America Glucagon Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 39. Latin America Glucagon Sales Market Share by Country (2019-2030)
    Figure 40. Latin America Glucagon Revenue Market Share by Country (2019-2024)
    Figure 41. Latin America Glucagon Sales Market Share by Type (2019-2024)
    Figure 42. Latin America Glucagon Sales Market Share by Application (2019-2024)
    Figure 43. Middle East and Africa Glucagon Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 44. Middle East and Africa Glucagon Sales Market Share by Country (2019-2030)
    Figure 45. Middle East and Africa Glucagon Revenue Market Share by Country (2019-2030)
    Figure 46. Middle East and Africa Glucagon Sales Market Share by Type (2019-2024)
    Figure 47. Middle East and Africa Glucagon Sales Market Share by Application (2019-2024)
    Figure 48. Glucagon Supply Chain (Upstream and Downstream Market)
    Figure 49. Global Production Market Share of Glucagon Raw Materials by Region in 2023
    Figure 50. Glucagon Distribution Channels
    Figure 51. Global Glucagon Percentage 2019-2030: Indirect Sales VS Direct Sales
    Figure 52. Global Glucagon Percentage 2019-2030: Online Sales VS Offline Sales
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS